Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Emma, Medin"'
Autor:
Mark Edmondson-Jones, Therese Dibbern, Marcus Hultberg, Bengt Anell, Emma Medin, Yang Feng, Carla Talarico
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 2, Pp 517-526 (2021)
Seven-valent pneumococcal conjugate vaccine (PCV7) was introduced to Sweden in 2009 and replaced by pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) or 13-valent PCV (PCV13) from late 2009. A retrospective cohort
Externí odkaz:
https://doaj.org/article/87ca0e55e30c48c59aaacf4031c947dd
Autor:
Mark Edmondson-Jones, Therese Dibbern, Marcus Hultberg, Bengt Anell, Emma Medin, Yang Feng, Carla Talarico
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1 (2022)
In Sweden, the 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in 2009 and replaced by the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) or the 13-valent PCV (PCV13) from late 2009. We assessed t
Externí odkaz:
https://doaj.org/article/0cd23638c072476c848b6b60d1cb50d3
Autor:
Stephen Palmer, Isabelle Borget, Tim Friede, Don Husereau, Jonathan Karnon, Ben Kearns, Emma Medin, Elisabeth F.P. Peterse, Sven L. Klijn, Elisabeth J.M. Verburg-Baltussen, Elisabeth Fenwick, John Borrill
Publikováno v:
Value in Health. 26:185-192
Parametric models are routinely used to estimate the benefit of cancer drugs beyond trial follow-up. The advent of immune checkpoint inhibitors has challenged this paradigm, and emerging evidence suggests that more flexible survival models, which can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa0ec9447a04f3db0908b211e8cb47f5
https://doi.org/10.1016/j.jval.2022.07.009
https://doi.org/10.1016/j.jval.2022.07.009
Autor:
Caitlin Smare, Meena Venkatachalam, Emma Medin, Marcus Hultberg, John R Penrod, Nadine Hertel, Michael Lees, Christoffer Holmberg
Publikováno v:
Nordic Journal of Health Economics, Vol 7, Iss 1 (2019)
The cost-effectiveness of nivolumab versus docetaxel in patients with previously treated non-small cell lung cancer (NSCLC) was estimated in a cohort-based, partitioned survival model with three health states (progression-free, progressed disease, an
Externí odkaz:
https://doaj.org/article/f643ce982bca4e41a7f3ac731d1b2599
Autor:
Mark Edmondson-Jones, Emma Medin, Carla Talarico, Therese Dibbern, Marcus Hultberg, B Anell, Yang Feng
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Seven-valent pneumococcal conjugate vaccine (PCV7) was introduced to Sweden in 2009 and replaced by pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) or 13-valent PCV (PCV13) from late 2009. A retrospective cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a5f814f33c86a3fa15e82f0ca8bba92
https://doi.org/10.1080/21645515.2020.1775455
https://doi.org/10.1080/21645515.2020.1775455
Autor:
Emma Medin, Mark Edmondson-Jones, B Anell, Carla Talarico, Marcus Hultberg, Therese Dibbern, Yang Feng
Publikováno v:
Human vaccinesimmunotherapeutics. 18(1)
In Sweden, the 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in 2009 and replaced by the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) or the 13- valent PCV (PCV13) from late 2009. We assessed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9042c572bf4ae8535d0f52dbb9338168
https://pubmed.ncbi.nlm.nih.gov/34319865
https://pubmed.ncbi.nlm.nih.gov/34319865
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e68861 (2013)
BackgroundThe global burden of disease has shifted from communicable diseases in children to chronic diseases in adults. This epidemiologic shift varies greatly by region, but in Europe, chronic conditions account for 86% of all deaths, 77% of the di
Externí odkaz:
https://doaj.org/article/0767cb3d9fda41f7bb3f525d628d7ca6
Publikováno v:
BMC Psychiatry, Vol 18, Iss 1, Pp 1-11 (2018)
BMC Psychiatry
BMC Psychiatry
Background This observational, cross-sectional, retrospective chart review aimed to identify factors determining health-related quality of life (HRQoL) in adults with newly diagnosed attention-deficit/hyperactivity disorder (ADHD) in Sweden. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce9ab50031e7d9470516af0dcb6bc49a
http://link.springer.com/article/10.1186/s12888-018-1803-y
http://link.springer.com/article/10.1186/s12888-018-1803-y
Autor:
Marcus Hultberg, Christoffer Holmberg, Meena Venkatachalam, M Lees, John R. Penrod, Caitlin Smare, Emma Medin, N. Hertel
Publikováno v:
Nordic Journal of Health Economics, Vol 7, Iss 1 (2019)
Nordic Journal of Health Economics (2020)
Nordic Journal of Health Economics (2020)
The cost-effectiveness of nivolumab versus docetaxel in patients with previously treated non-small cell lung cancer (NSCLC) was estimated in a cohort-based, partitioned survival model with three health states (progression-free, progressed disease, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a97f1ed39d2a46325c2ee6cfb323a4f
https://journals.uio.no/NJHE/article/view/5453
https://journals.uio.no/NJHE/article/view/5453
Publikováno v:
Neuropsychiatric Disease and Treatment
Maria Polyzoi,1 Ewa Ahnemark,2 Emma Medin,1,3 Ylva Ginsberg4,5 1PAREXEL International, Stockholm, Sweden; 2Medical Affairs Department, Shire Sweden AB, Stockholm, Sweden; 3Department of Learning, Informatics, Management and Ethics, Karolinska Institu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::312bb1c7c605e1a25684fac09e5ca545
https://www.dovepress.com/estimated-prevalence-and-incidence-of-diagnosed-adhd-and-health-care-u-peer-reviewed-article-NDT
https://www.dovepress.com/estimated-prevalence-and-incidence-of-diagnosed-adhd-and-health-care-u-peer-reviewed-article-NDT